S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer
Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This phase II trial on the assumption that S-1 combined with Leucovorin may have better
efficacy and safety than simplified 5-FU/LV infusion therapy in elderly patients with
advanced colorectal cancer.